Zhang Jiafang, Yip Rowena, Taioli Emanuela, Flores Raja M, Henschke Claudia I, Yankelevitz David F, Schwartz Rebecca M
Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J Thorac Dis. 2024 Jan 30;16(1):147-160. doi: 10.21037/jtd-23-1201. Epub 2024 Jan 9.
Few studies have examined the differential impact of stereotactic body radiotherapy (SBRT) and surgery for early-stage non-small cell lung cancer (NSCLC) on quality of life (QoL) during the first post-treatment year.
A prospective cohort of stage IA NSCLC patients undergoing surgery or SBRT at Mount Sinai Health System had QoL measured before treatment, and 2, 6, and 12 months post-treatment using: 12-item Short Form Health Survey version 2 (SF-12) [physical component summary (PCS) and mental component summary (MCS)], Functional Assessment of Cancer Therapy-Lung Cancer Subscale (FACT-LCS), and the Patient Health Questionnaire-4 (PHQ-4) measuring depression and anxiety. Locally weighted scatterplot smoothing (LOWESS) was fitted to identify the best interval knot for the change in the QoL trends post-treatment, adjusted piecewise linear mixed effects model was developed to estimate differences in baseline, 2- and 12-month scores, and rates of change.
In total, 503 (88.6%) patients received surgery and 65 (11.4%) SBRT. LOWESS plots suggested QoL changed at 2 months post-surgery. Worsening in PCS was observed for both surgery and SBRT within 2 months after treatment but was only significant for surgical patients (-2.11, P<0.001). Two months later, improvements were observed for surgical but not SBRT patients (0.63 -0.30, P<0.001). Surgical patients had significantly better PCS (P<0.001) and FACT-LCS (P<0.001) scores 1-year post-treatment compared to baseline, but not SBRT patients. Both surgical and SBRT patients reported significantly less anxiety 1-year post-treatment compared to baseline (P<0.001 and P=0.03). Decrease in depression from baseline to 1-year post-treatment was only significant for surgical patients (P<0.001).
Post-treatment, surgical patients exhibited improvements in physical health and reductions in lung cancer symptoms following initial deterioration within the first two months; in contrast, SBRT patients showed persistent decline in these areas throughout the year. Nonetheless, improved mental health was noted across both patient categories post-treatment. Targeted interventions and continuous monitoring are recommended during the initial 2 months post-surgery and throughout the year post-SBRT to alleviate physical and mental distress in patients.
很少有研究探讨立体定向体部放疗(SBRT)和手术治疗早期非小细胞肺癌(NSCLC)对治疗后第一年生活质量(QoL)的不同影响。
在西奈山医疗系统对接受手术或SBRT的IA期NSCLC患者进行前瞻性队列研究,在治疗前、治疗后2、6和12个月使用以下方法测量生活质量:12项简短健康调查问卷第2版(SF-12)[身体成分总结(PCS)和精神成分总结(MCS)]、癌症治疗功能评估-肺癌子量表(FACT-LCS)以及测量抑郁和焦虑的患者健康问卷-4(PHQ-4)。采用局部加权散点图平滑法(LOWESS)确定治疗后生活质量趋势变化的最佳间隔节点,建立调整后的分段线性混合效应模型来估计基线、2个月和12个月时的得分差异以及变化率。
共有503例(88.6%)患者接受了手术,65例(11.4%)接受了SBRT。LOWESS图显示术后2个月生活质量发生变化。治疗后2个月内,手术和SBRT患者的PCS均出现恶化,但仅手术患者的恶化具有统计学意义(-2.11,P<0.001)。两个月后,手术患者的生活质量有所改善,而SBRT患者则没有(0.63对-0.30,P<0.001)。与基线相比,治疗后1年手术患者的PCS(P<0.001)和FACT-LCS(P<0.001)得分显著更高,但SBRT患者并非如此。与基线相比,治疗后1年手术和SBRT患者报告的焦虑均显著减少(P<0.001和P=0.03)。从基线到治疗后1年,仅手术患者的抑郁有显著下降(P<0.001)。
治疗后,手术患者在最初两个月内身体状况恶化后,身体健康状况有所改善,肺癌症状减轻;相比之下,SBRT患者在这一年中这些方面持续下降。尽管如此,两类患者治疗后的心理健康均有所改善。建议在术后最初2个月和SBRT后全年进行有针对性的干预和持续监测,以减轻患者的身心痛苦。